Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intracerebral hemorrhage.

J M Gebel1, J P Broderick

  • 1Assistant Professor of Neurology, Stroke Institute, University of Pittsburgh Medical Center, PA 15213, USA.

Neurologic Clinics
|April 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Migraine-Associated Common Genetic Variants Confer Greater Risk of Posterior vs. Anterior Circulation Ischemic Stroke☆.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2022
Same author

Detailed phenotyping of posterior vs. anterior circulation ischemic stroke: a multi-center MRI study.

Journal of neurology·2019
Same author

<i>Reply</i>.

AJNR. American journal of neuroradiology·2017
Same author

Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes.

AJNR. American journal of neuroradiology·2016
Same author

Administration of S-methyl-L-thiocitrulline protects against brain injuries after intracerebral hemorrhage.

Neuroscience·2014
Same author

Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1 h of cerebral ischemia and 23 h of reperfusion.

Neuroscience·2013
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Intracerebral hemorrhage (ICH) remains a leading cause of stroke-related death and disability, particularly in young Black individuals. Despite diagnostic advances, effective treatments are lacking, necessitating urgent clinical trials for new therapeutic strategies.

Area of Science:

  • Neurology
  • Neurosurgery
  • Public Health

Background:

  • Intracerebral hemorrhage (ICH) accounts for a significant proportion of strokes, leading to high rates of morbidity and mortality.
  • This is particularly pronounced in young Black populations.
  • Despite advances in diagnostic imaging like CT scans, patient outcomes have not significantly improved.

Purpose of the Study:

  • To highlight the urgent need for effective therapeutic interventions for ICH.
  • To emphasize the lack of proven treatments despite aggressive medical and surgical interventions.
  • To underscore the importance of timely treatment and the necessity for large-scale clinical trials.

Main Methods:

  • Review of current diagnostic and therapeutic approaches for ICH.

Related Experiment Videos

  • Analysis of existing clinical trial data regarding treatment efficacy.
  • Identification of emerging therapeutic strategies from experimental and clinical research.

    • Main Results:

    • No current therapeutic modality has demonstrated a clear benefit on long-term outcomes in randomized trials.
    • Aggressive interventions are often employed due to the critical nature of ICH presentations.
    • Emerging research suggests potential new therapeutic strategies, with time to treatment being a critical factor.

    Conclusions:

    • Large, prospective, randomized, placebo-controlled trials are essential.
    • These trials should evaluate current treatment options and investigate novel therapeutic modalities.
    • Addressing the high burden of ICH requires robust scientific investigation and evidence-based treatment strategies.